日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

缺氧选择性细胞毒素 NLCQ-1 (NSC 709257) 在用作放射疗法的辅助药物时,可控制转移性疾病

Lunt S J, Cawthorne C, Ali M, Telfer B A, Babur M, Smigova A, Julyan P J, Price P M, Stratford I J, Bloomer W D, Papadopoulou M V, Williams K J

17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response

17β-雌二醇治疗可调节MDA231肿瘤中一氧化氮合酶的活性,进而影响肿瘤生长和放射反应。

Chinje, E C; Williams, K J; Telfer, B A; Wood, P J; van der Kogel, A J; Stratford, I J